Surveillance for biotech performance-enhancing drugs was increased at last month's Olympic Games. Will athletes turn to more stealth enhancements in the future? Laura DeFrancesco investigates.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Caitlin, D.H. Rapid Comm. Mass Spectrom. 18, 1245–1249 (2004).
Yaeger, D. & Baumberger, M. Sports Illustrated, 96, 72–76 (April 14, 1997).
Barton-Davis, E.R. et al. Proc. Nat. Acad. Sci. USA 95, 15603–15607 (1998).
Lee, S. et al. J. Appl. Physiol. 96, 1097–1104 (2004).
Sweeney, H.L. Sci. Am. 291, 62–69 (2004).
Guangping, G. Blood 103, 3300–3302 (2004).
Moullier, P. Mol. Ther. 10, 409–410 (2004).
Yang, N. et al. Am. J. Hum. Genet. 73, 627–631 (2003).
Myerson, S. et al. J. Appl. Physiol. 87, 1313–1316 (1999).
Author information
Authors and Affiliations
Related links
Rights and permissions
About this article
Cite this article
DeFrancesco, L. The faking of champions. Nat Biotechnol 22, 1069–1071 (2004). https://doi.org/10.1038/nbt0904-1069
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0904-1069
